Iminodibenyl
Especificaciones
494-19-9Número CAS
207-787-1Número CE
6,11-dihydro-5H-benzo[b][1]benzazepineNombre IUPAC
C14H13NFórmula química
195.26 g/molPeso molecular
Iminodibenzyl; 494-19-9; 10,11-Dihydro-5H-dibenzo[b,f]azepine; Iminobibenzyl; 10,11-Dihydro-5H-dibenz[b,f]azepine; 2,2'-Iminodibenzyl; 2,2'-Iminobibenzyl; Iminodibenyl; 5H-Dibenz[b,f]azepine, 10,11-dihydro-; 10,11-Dihydrodibenz(b,f)azepine; RP 23669; NSC 72110; 10,11-Dihydro-5-dibenz(b,f)azepine; DTXSID8049414; 5H-Dibenz(b,f)azepine, 10,11-dihydro-; EINECS 207-787-1; 10,11-Dihydro-5H-dibenz(b,f)azepine; BRN 0152732; 262BX7OE3U; AI3-39165; 10,11-Dihydrodibenz[b,f]azepine; NSC-72110; DTXCID7029374; EC 207-787-1; 5-20-08-00092 (Beilstein Handbook Reference); CARBAMAZEPINE IMPURITY E [IP]; CARBAMAZEPINE IMPURITY E [EP IMPURITY]; 10,11-DIHYDRO-5H-DIBENZ(B.F)AZEPINE; 10,11-DIHYDRO-5H-DIBENZO(B,F)AZEPINE; TRIMIPRAMINE MALEATE IMPURITY F [EP IMPURITY]; CLOMIPRAMINE HYDROCHLORIDE IMPURITY E [EP IMPURITY]; CARBAMAZEPINE IMPURITY E (IP); CARBAMAZEPINE IMPURITY E (EP IMPURITY); TRIMIPRAMINE MALEATE IMPURITY F (EP IMPURITY); CLOMIPRAMINE HYDROCHLORIDE IMPURITY E (EP IMPURITY); TRIMIPRAMINE MALEATE IMPURITY, IMINODIBENZYL-(USP IMPURITY); TRIMIPRAMINE MALEATE IMPURITY, IMINODIBENZYL-[USP IMPURITY]; RefChem:790828; 5H-Dibenzb,fazepine, 10,11-dihydro-; 207-787-1; InChI=1/C14H13N/c1-3-7-13-11(5-1)9-10-12-6-2-4-8-14(12)15-13/h1-8,15H,9-10H; 6,11-dihydro-5H-benzo[b][1]benzazepine; MFCD00005070; CHEMBL63054; CAS-494-19-9; Oxcarbazepine Impurity 11; 10,11-Dihydro-5H-dibenzo[b,f]azepine (Iminodibenzyl); UNII-262BX7OE3U; Iminodibenzyyl; Clomipramine HCl EP Impurity E; 10,f]azepine; Carbamazepine impurity E; Oprea1_136738; SCHEMBL407439; SCHEMBL615272; SCHEMBL688175; SCHEMBL688577; SCHEMBL689201; SCHEMBL704908; orb1224947; orb1310435; SCHEMBL1038154; 10H,11H-dibenzo[b,f]azepine; WLN: T C676 BM&T&J; 5H-Dibenz[b, 10,11-dihydro-; HY-B2131; NSC72110; STR02159; Tox21_113758; Tox21_202836; BBL011749; BDBM50012879; EBC-03680; SBB003595; STK299261; 2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaene; AKOS000119140; AC-7238; FI01651; GF-0137; NCGC00253630-01; NCGC00260382-01; 10,11-Dihydro-5H-dibenz [b,f]azepine; PD065559; SY005302; 5H,10H,11H-dibenzo[b,f]azaperhydroepine; 10,11-Dihydro-5H-dibenzo[b,f]azepine #; 5H-Dibenzo[b,f]azepine, 10,11-dihydro-; CS-0020288; D0269; NS00005580; ST45025644; EN300-19086; 10,11-Dihydro-5H-dibenz[b,f]azepine, 97%; IMINODIBENZYL TRIMIPRAMINE [USP IMPURITY]; F210272; SR-01000395830; Q1096623; SR-01000395830-1; Iminodibenzyl (10,11-Dihydro-5H-dibenzo[b,f]azepine); Z104472710; Iminodibenzyl, United States Pharmacopeia (USP) Reference Standard; 2-azatricyclo[9.4.0.0,3,8]pentadeca-1(15),3,5,7,11,13-hexaene; Carbamazepine EP Impurity E; Clomipramine EP Impurity E; Trimipramine Maleate EP Impurity F; Iminodibenzyl, Pharmaceutical Secondary Standard; Certified Reference MaterialSinónimos